TRONCI, ELISABETTA
 Distribuzione geografica
Continente #
EU - Europa 83.516
NA - Nord America 3.331
AS - Asia 1.052
SA - Sud America 162
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 88.087
Nazione #
IT - Italia 82.687
US - Stati Uniti d'America 3.293
SG - Singapore 429
CN - Cina 427
UA - Ucraina 244
DE - Germania 200
SE - Svezia 168
BR - Brasile 137
FI - Finlandia 70
GB - Regno Unito 65
VN - Vietnam 57
KR - Corea 41
CA - Canada 30
IN - India 22
FR - Francia 21
RU - Federazione Russa 19
HK - Hong Kong 16
AR - Argentina 12
JP - Giappone 12
BE - Belgio 11
CZ - Repubblica Ceca 8
IQ - Iraq 8
NL - Olanda 8
ZA - Sudafrica 8
BD - Bangladesh 7
AE - Emirati Arabi Uniti 6
TR - Turchia 6
MX - Messico 5
CL - Cile 4
ID - Indonesia 4
KE - Kenya 4
MA - Marocco 4
PK - Pakistan 4
PL - Polonia 4
EC - Ecuador 3
EG - Egitto 3
ES - Italia 3
EU - Europa 3
PY - Paraguay 3
SA - Arabia Saudita 3
TH - Thailandia 3
IE - Irlanda 2
JO - Giordania 2
AO - Angola 1
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CO - Colombia 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
MT - Malta 1
NZ - Nuova Zelanda 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 88.087
Città #
Cagliari 79.166
Uta 3.352
Fairfield 420
Woodbridge 360
Ashburn 298
Chandler 203
Ann Arbor 201
Houston 182
Wilmington 179
Singapore 177
Seattle 152
Cambridge 151
Jacksonville 126
Nyköping 121
Boardman 114
Beijing 111
Dallas 110
Dearborn 108
Nanjing 53
Shanghai 53
Los Angeles 45
Santa Clara 45
Seoul 38
New York 36
Helsinki 27
Boston 23
Hefei 22
Ho Chi Minh City 22
San Diego 22
Milan 20
Munich 14
The Dalles 13
Dong Ket 12
Guangzhou 12
Tianjin 12
Brussels 11
Buffalo 11
Changsha 11
Nanchang 11
Redwood City 11
Shenyang 11
Tokyo 11
Verona 11
Hong Kong 10
Mountain View 10
São Paulo 10
Toronto 10
Hebei 9
Sassari 9
Council Bluffs 8
London 8
Montreal 8
Norwalk 8
Phoenix 8
Redondo Beach 8
Falls Church 7
Hangzhou 7
Turku 7
Brno 6
Brooklyn 6
Frankfurt am Main 6
Jinan 6
Oristano 6
Padova 6
Washington 6
Central 5
Hanoi 5
New Delhi 5
Rome 5
San Francisco 5
San Jose 5
Ankara 4
Florence 4
Grottammare 4
Jiaxing 4
Johannesburg 4
Lauterbourg 4
Nairobi 4
Ningbo 4
Orange 4
Pune 4
Stockholm 4
Zhengzhou 4
Belo Horizonte 3
Betim 3
Borås 3
Brasília 3
Casablanca 3
Chennai 3
Chicago 3
Clifton 3
Columbus 3
Detroit 3
Edinburgh 3
Elk Grove Village 3
Kilburn 3
Portsmouth 3
Riyadh 3
Secaucus 3
Tossicia 3
Totale 86.386
Nome #
5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction 5.768
Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease. 4.296
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease 4.262
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 4.045
Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia 3.667
Effect of selective and non-selective serotonin receptor activation on l-DOPA-induced therapeutic efficacy and dyskinesia in parkinsonian rats 3.529
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 3.519
The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation 3.419
null 2.940
Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats 2.839
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia 2.543
The serotonergic system in levodopa-induced dyskinesia 2.527
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding 2.301
null 2.298
null 2.247
5-HT1 receptor agonists for the treatment of L-DOPA-induced dyskinesia: From animal models to clinical investigation 2.203
Foetal cell transplantation for Parkinson's disease: focus on graft-induced dyskinesia 2.149
Serotonin system implication in L-DOPA-induced dyskinesia: from animal models to clinical investigations 2.135
Amphetamine-induced rotation and L-DOPA-induced dyskinesia in the rat 6-OHDA model: A correlation study 2.128
Role of serotonin neurons in L-DOPA- and graft-induced dyskinesia in a rat model of parkinson's disease 2.127
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug 2.057
Caffeine consumption and changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine 1.757
Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and5-HT1B receptor agonists in the rat Parkinson model 1.515
null 1.471
BDNF Overexpression Increases Striatal D3Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia 1.370
Long-term increase in GAD67 mRNA expression in the central amygdala of rats sensitized by drugs and stress 1.300
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats 1.254
Caffeine sensitization and cross-sensitization with amphetamine: association to post-synaptic changes in rat striatal neurons 1.221
null 1.194
Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats 1.134
Dopamine and adenosine receptor interaction as the basis for the treatment of Parkinson's disease 1.092
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease 1.059
Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease 1.047
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms 1.045
CAFFEINE SESITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST-SYNAPTIC CHANGES IN RAT STRIATAL NEURONS 1.025
null 1.012
CAFFEINE SENSITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST BUT NOT PRE-SYNAPTIC CHANGES IN RAT STRIATAL NEURON 1.009
null 967
Changes in the expression of tonic and phasic neurochemical markers of activity in a rat model of L-DOPA induced dyskinesia 949
Changes in the expression of tonic and phasic neurochemical markers of activity in a rat model of L-DOPA induced dynskinesia 923
Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats 898
Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment 854
BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats 656
Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons 277
Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats 239
Totale 88.267
Categoria #
all - tutte 104.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.125


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.931 0 0 0 0 0 2.287 1.509 1.263 366 959 961 586
2021/20223.592 394 366 173 182 253 273 204 158 271 431 492 395
2022/20235.204 349 569 563 435 460 580 293 349 389 406 545 266
2023/20245.597 227 174 225 283 508 834 880 378 214 395 604 875
2024/202516.813 4.751 4.481 4.113 1.153 579 619 676 52 124 73 89 103
2025/20261.090 186 93 249 214 182 166 0 0 0 0 0 0
Totale 88.267